TABLE 3.
Dog no. | C6 antibody level (U/ml) at indicated no. of mos posttreatmentb
|
Treatment groupc | |||
---|---|---|---|---|---|
0 | 3 | 6 | 12 | ||
L7 | <10 | 10 | 14 | <10 | AM |
L11 | 10 | 19 | 17 | <10 | AM |
L12 | 10 | 10 | <10 | <10 | AM |
L13 | 11 | <10 | <10 | <10 | HD |
L14 | 12 | 14 | <10 | HD | |
L15 | 13 | 10 | HD | ||
L16 | 14 | 12 | <10 | <10 | HD |
L17 | 15 | 23 | 13 | <10 | LD |
L18 | 19 | 16 | 17 | HD | |
L19 | 19 | 19 | 19 | 12 | HD |
L20 | 21 | <10 | <10 | <10 | AM |
L21 | 21 | 25 | 25 | LD | |
L22 | 21 | 21 | 11 | AM | |
L23 | 22 | 19 | 15 | LD |
The C6 levels in samples from dogs L1, L2, L3, L4, L5, L6, L8, L9, and L10 were <10 U/ml at the initial time point and remained <10 U/ml at all time points tested.
Time points that did not occur at 3, 6, or 12 months were adjusted to the nearest value, which was typically within ±1 month.
AM, amoxicillin; LD, low dose of doxycycline; HD, high dose of doxycycline.